Table 2 Treatment-emergent adverse drug reactions that were possibly or probably related to treatment
Selepressin 1.25 ng/kg/minute (n = 10) | Selepressin 2.5 ng/kg/minute (n = 19) | Selepressin 3.75 ng/kg/minute (n = 2) | Placebo (n = 21) | |
|---|---|---|---|---|
No. of subjects (%), events | No. of subjects (%), events | No. of subjects (%), events | No. of subjects (%), events | |
Cardiac disorder | ||||
Atrial fibrillation | 1 (5), 1 | |||
Cyanosis | 1 (5), 1 | |||
Myocardial ischemia | 1 (50), 1 | |||
Myocarditis | 1 (5), 1 | |||
Metabolism and nutritional disorders | ||||
Hyperlactatemia | 1 (5), 1 | |||
Skin and subcutaneous tissue disorders | ||||
Macular rash | 1 (5), 1 | |||
Vascular disorders | ||||
Hypertension | 2 (11), 2 | |||
Peripheral ischemia | 1 (5), 1 | |||